Providence St. Joseph Hospital's Cancer Program Re-Accredited by the American College of Surgeons Commission on Cancer

Providence St. Joseph Hospital in Eureka is excited to announce that its esteemed cancer program has been re-accredited by the American College of Surgeons (ACS) Commission on Cancer (CoC) for the next three years (2024-2026). 

According to St. Joseph Hospital Cancer Program Medical Director, Ellen Mahoney, M.D., the recognition from a prestigious and rigorous accrediting organization like the Commission on Cancer is an incredible validation of staff and the program.

“We have worked for several years to streamline our process and to provide the best in modern multidisciplinary up-to-date cancer care for our neighbors on the North Coast,” said Mahoney, who came to Humboldt from Stanford Medical Center in 2000. “Through all these years, I have been privileged to work with a skilled, generous, and dedicated group of people at all levels in our program. They come to work every day with full-hearted eagerness to learn and to care for the families in our community facing the most challenging situations in their lives.”

As the nation's leading organization devoted to enhancing survival rates and quality of life for cancer patients, the CoC's accreditation is a voluntary process that rigorously assesses cancer programs against meticulous standards of cancer care. 

The cancer program underwent a comprehensive review by CoC site reviewers in late 2023, evaluating compliance with the CoC's Optimal Resources for Cancer Care standards. They scrutinized the program's data pertaining to cancer prevention, early detection, cancer staging, treatment, and survivorship. 

St. Joseph Hospital Cancer Program Director, Priscilla Lynn, R.N. shared the CoC surveyor stated, "The St. Joseph Cancer Program has continued to grow and excel; this site review identified many strengths, all demonstrating their commitment to excellent patient care." 

Meeting the rigorous expectations of 35 accreditation standards set forth by the Commission on Cancer with no deficiencies is an exceptional accomplishment, according to Lynn. “This recognition assures our patients that they are receiving care that meets the most stringent national standards, instilling confidence and trust in the treatments they receive.”